Head-to-head · Cost-Efficiency Index
Corsica Health vs Rewinding RX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Corsica Health
Shoppers who want compounded and brand-name GLP-1 pricing shown side by side on one platform.
Visit Corsica HealthRewinding RX
Shoppers who want a flat, no-dose-upcharge price and are comparing the standard-dose product specifically, not the cheaper microdose line.
Visit Rewinding RXThe verdict
Corsica Health and Rewinding RX tie on the Cost-Efficiency Index at 66/100, so neither wins outright on the numbers. For most shoppers we'd start with Corsica Health (ranked #146, a hair above #150) — Shoppers who want compounded and brand-name GLP-1 pricing shown side by side on one platform. But Rewinding RX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Corsica Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Corsica Health | Rewinding RX |
|---|---|---|
| Cost-Efficiency Index | 66/100 | 66/100 |
| Semaglutide / mo | $149/mo (starting dose, compounded) | $139/mo (microdose tier, compounded) |
| Tirzepatide / mo | $249/mo (starting dose, compounded) | $189/mo (microdose tier, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,668 |
| Tirzepatide / yr (modeled) | $2,988 | $2,268 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #146 | #150 |
Corsica Health
66/100Where the value is
- Publishes real starting dollar prices for THREE tiers on one page — compounded semaglutide, compounded tirzepatide, and brand-name Ozempic/Wegovy — a genuine transparency advantage few competitors offer at once
- Compounded semaglutide's starting price fell from $199/mo to $149/mo since a prior 2026-07-20 check — a real, verifiable decrease
- Free shipping and provider consultation included in the listed starting price
The tradeoffs
- Listed prices are floor figures for the lowest dose tier only — no published ladder for what higher, titrated doses cost
- The '15-20% average weight change' and '4.8/5 satisfaction' figures are the company's own self-reported claims, not independently sourced
Rewinding RX
66/100Where the value is
- Flat pricing within each product regardless of dose
- Publishes the FDA compounded-medication disclaimer and states pharmacies are '503A'/'503B' FDA-regulated facilities
- Corporate entity is disclosed (Rewinding RX Ltd.)
The tradeoffs
- Four separate GLP-1 SKUs exist at four different prices under similar names
- No compounding pharmacy is individually named, only generic '503A'/'503B' language
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.